rivaroxaban
bayer
['invictus']
intriguing results from the #invictus trial vka still the oac treatment of choice in rheumatic #af - such an important study #esccongress 
Professor of Cardiology, Copenhagen Univ. Hosp. Herlev & Gentofte.  Director of Research, The Danish Heart Foundation